BioNexus Gene Lab (BGLC) Other Operating Expenses (2024 - 2026)

BioNexus Gene Lab's Other Operating Expenses history runs 3 years deep, the most recent figure standing at $255230.0 for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 0.86% year-over-year to $255230.0; the TTM figure through Mar 2026 stood at $1.4 million (down 8.01% YoY), while the FY2025 annual figure was $1.4 million, up 11.34% from the prior year.
• Other Operating Expenses came in at $255230.0 for Q1 2026 at BioNexus Gene Lab, down from $679050.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $1.1 million in Q4 2024 to a low of -$1.3 million in Q1 2024.
• A 3-year average of $171832.4 and a median of $257440.0 in 2025 frame the typical range for Other Operating Expenses.
• On a YoY basis, Other Operating Expenses climbed as much as 138.95% in 2025 and fell as far as 47.29% in 2025.
• BioNexus Gene Lab's Other Operating Expenses stood at $1.1 million in 2024, then slumped by 35.4% to $679050.0 in 2025, then slumped by 62.41% to $255230.0 in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $255230.0, $679050.0, and $281696.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison